4Tian C, Markman M, Zaino R, et al. CA- 125 change after chemother- apy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study [J]. Cancer,2009,115(7): 1395-1403.
5Medeiros L R, Rosa D D, Da R M, et al. Accuracy of CA125 in the diagnosis of ovarian tumors: a quantitative systematic review [J]. Eur J Obstet Gynecol Reprod Biol,2009,142(2):99-105.
6Milojkovic M, Hrgovie Z, Hrgovie I, et al. Significance of CA125 sermn level in discrimination between benign and malignant masses in the DelvisI-J]. Arch Gvnecol Obstet.2004,269(3):176-180.
7Gemer O, Segal S, Kopmar A. Preoperative CA-125 level as a predic- tor of non optimal cytoredution of advanced epithelial ovarian cancer [J]. Aeta Ohstet Gynecol Scand, 2001,80(6) : 583-585.
8Kirehhoff C, Habben I, Lvell R,et al. A major human epididymis- specific cDNA Encodes a protein with sequence homology to extracellular proteinase inhibitors [J]. Biol Rep-rod, 1991,45(2):350-357.
9Sehummer M, Ng W V,Bumgarner R E, et al. Comparative hybridiza- tion of an array of 21,500 ovarian eDNAs for the discovery of genes over-expressed in ovarian car -cinomas[J]. Gene, 1999,238 (2) : 375-385.
10Drapkin R, Von Horsten H H, Lin Y, et al. Human epididymis pro- tein 4 (HE 4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carei-nomas[J]. Cancer Res, 2005,65 (6) : 2162- 2169.
3Diamandis EP, Yousef GM, Clements J, et al. New nomenclature for the human tissue kallikrein gene family [J]. Clin Chem, 2000, 46 (11): 1855-1858.
4Luo LY, Katsaros D, Scorilas A, et al. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma[J]. ClinCaneer Res, 2001, 7 (8), 2372-2379.
5Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement of CA125 in epithelial ovarian cancer[J]. Gynecol Oncol, 2005, 99 (22):267-277.
6Jacobs J, Menon U. Progress and challenges in screening for early detection of ovarian cancer[J]. Mol Cell Proteomics, 2004, 3 (4): 355-366.
7Paliouras M, Borgono C, Eleftherios P, et al. Human tissue kallikreins: The cancer biomarker family[J]. Cancer Lett, 2007, 249 (1): 61-79.
8Kioulafa M, Kaklamanis L, Stathopoulos E, et al. Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer [J]. Ann Oncol, 2009, 20 (6): 1020-1025.
9Lehtovirta P, Apter D, STENMAN U H. Serum CA 125 Levels during the menstrual cycle. B JOG:An International Journal of Obstetrics & Gynaecology, 1990,97(10):930-933.
2Toriihara A,Taniguchi Y,Negi M,et al.FDG PET/CT of a benign o- varian Brenner tumor[J].Clinical imaging, 2012,36(5 ) : 650-653.
3Glaser G,Torres M,Kim B,et al.The use of CT findings to predict ex- tent of tumor at primary surgery for ovarian cancer[J].Gynecologic Oncolo- gy: An International Journal, 2013,130 (2) : 280-283.
